Alterations in eicosanoid levels during U937 bcl-xL tumour growth suppression and recovery in NU/NU mice in vivo-Involvement of phospholipase A2

Prostaglandins and Other Lipid Mediators

Volumn 107, Issue , 2013, Pages 43-47

  Pace Asciak, Cecil R ^a,b   Li, Xiang ^a   Reynaud, Denis ^a   Qiao, Na ^a   Demin, Peter ^a   Abdelhaleem, Mohamed ^a  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Antagonists; Eicosanoids; Hepoxilins; LCMSMS; Phospholipase; Tumours

Indexed keywords

12 HYDROXYICOSATETRAENOIC ACID; ANTINEOPLASTIC AGENT; ARACHIDONATE 12 LIPOXYGENASE; ARACHIDONIC ACID; HEPOXILIN; ICOSANOID; IMATINIB; OMEGA 6 FATTY ACID; PBT 4; PHOSPHOLIPASE A2; PROTEIN BCL XL; UNCLASSIFIED DRUG; UNSATURATED FATTY ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL STRAIN U937; CONTROLLED STUDY; FATTY ACID ANALYSIS; FEMALE; HUMAN; HUMAN CELL; IN VIVO STUDY; LEUKEMIA CELL; MEASUREMENT; MONOCYTIC LEUKEMIA; MOUSE; NONHUMAN; TREATMENT DURATION; TUMOR GROWTH; TUMOR VOLUME; TUMOR XENOGRAFT;

ANTAGONISTS; EICOSANOIDS; HEPOXILINS; LCMSMS; PHOSPHOLIPASE; TUMOURS;

8,11,14-EICOSATRIENOIC ACID; ANIMALS; ANTINEOPLASTIC AGENTS; ARACHIDONIC ACID; BCL-X PROTEIN; CELL LINE, TUMOR; FEMALE; HUMANS; MICE; MICE, NUDE; PHOSPHOLIPASES A2; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84889098923     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2013.03.004     Document Type: Article

References (21)

1. C.R. Pace-Asciak Hepoxilins: a review on their cellular actions Biochim Biophys Acta 1215 1994 1 8 (Pubitemid 24345051)
2. C.R. Pace-Asciak Hepoxilins in cancer and inflammation-use of hepoxilin analogues Cancer Metastasis Rev 30 2011 493 506
3. C. Lefèvre, B. Bouadjar, and A. Karaduman Mutations in ichthyin a new gene on chromosome 5q33 in a new form of autosomal recessive congenital ichthyosis Hum Mol Genet 13 2004 2473 2482 (Pubitemid 39377851)
4. A.R. Brash, Y. Zheyong, W.E. Boeglin, and C. Schneider The hepoxilin connection in the epidermis FEBS J 274 2007 3494 3502 (Pubitemid 47052414)
5. D. Reynaud, P. Demin, and C.R. Pace-Asciak Hepoxilin A3-specific binding in human neutrophils Biochem J 313 January (Pt 2) 1996 537 541
6. D. Reynaud, P.M. Demin, and C.R. Pace-Asciak Coupling of hepoxilin A3-specific binding with calcium-mobilizing actions in human neutrophils Agents Actions Suppl 45 1995 291 296
7. 3 Tetrahedron Lett 34 1993 4305 4308
8. T. Hoshino, M. Okamoto, Y. Sakazaki, S. Kato, H.A. Young, and H. Aizawa Role of proinflammatory cytokines IL-18 and IL-1beta in bleomycin-induced lung injury in humans and mice Am J Respir Cell Mol Biol 41 December (6) 2009 661 670
9. N. Qiao, J. Lam, D. Reynaud, M. Abdelhaleem, and C.R. Pace-Asciak The hepoxilin analog PBT-3 induces apoptosis in BCR-ABL-positive K562 leukemia cells Anticancer Res 23 2003 3617 3622 (Pubitemid 37474304)
10. X. Li, N. Qiao, D. Reynaud, M. Abdelhaleem, and C.R. Pace-Asciak The hepoxilin analog, PBT-3, inhibits growth of K-562 CML solid tumors in vivo in nude mice IN VIVO 19 2005 185 190 (Pubitemid 40450394)
11. P. Le Coutre, L. Mologni, and L. Cleris In vivo eradication of human BCR/ABL-positive leukemia cells with an ABL kinase inhibitor J Natl Cancer Inst 91 1999 163 168 (Pubitemid 29042694)
12. O. Aprikian, D. Reynaud, and C. Pace-Asciak Neonatal dietary supplementation of arachidonic acid increases prostaglandin levels in adipose tissue but does not promote fat mass development in guinea pigs Am J Physiol Regul Integr Comp Physiol 293 November (5) 2007 R2006 R2012
13. V. Brahmbhatt, M. Oliveira, and M. Briand Protective effects of dietary EPA and DHA on ischemia-reperfusion-induced intestinal stress J Nutr Biochem July 2012
14. I.B. Copland, D. Reynaud, C. Pace-Asciak, and M. Post Mechanotransduction of stretch-induced prostanoid release by fetal lung epithelial cells Am J Physiol Lung Cell Mol Physiol 291 September (3) 2006 L487 L495
15. 3 in inflammatory events: a required role in neutrophil migration across intestinal epithelia Proc Natl Acad Sci USA 101 2004 7421 7426 (Pubitemid 38638048)
16. V.A. Blaho, M.W. Buczynski, C.R. Brown, and E.A. Dennis Lipidomic analysis of dynamic eicosanoid responses during the induction and resolution of Lyme arthritis J Biol Chem 284 August (32) 2009 21599 21612
17. A.M. Gregus, S. Doolen, and D.S. Dumlao Spinal 12-lipoxygenase-derived hepoxilin A3 contributes to inflammatory hyperalgesia via activation of TRPV1 and TRPA1 receptors Proc Natl Acad Sci USA 109 April (17) 2012 6721 6726
18. R.P. Jankov, X. Luo, and P. Demin Hepoxilin analogs inhibit bleomycin-induced pulmonary fibrosis in the mouse J Pharm Exp Ther 301 2002 435 440 (Pubitemid 34429952)
19. B.P. Hurley, W. Pirzai, K.L. Mumy, K. Gronert, and B.A. McCormick Selective eicosanoid-generating capacity of cytoplasmic phospholipase A2 in Pseudomonas aeruginosa-infected epithelial cells Am J Physiol Lung Cell Mol Physiol 300 February (2) 2011 L286 L294
20. X. Li, N. Qiao, D. Reynaud, M. Abdelhaleem, and C.R. Pace-Asciak PBT-3 a hepoxilin stable analog, causes long term inhibition of growth of K562 solid tumors in vivo Biochem Biophys Res Commun 338 2005 158 160 (Pubitemid 41540551)
21. R.H. Schaloske, and E.A. Dennis Phospholipase A2 superfamily and its group numbering system Biochem Biophys Acta 1761 2006 1246 1259 (Pubitemid 44755364)